Procter & Gamble Hygiene and Health Care Limited PGHH NSE
Procter & Gamble Hygiene and Health Care Limited manufactures and sells branded packaged fast-moving consumer goods in the feminine care and healthcare businesses in India and internationally. It operates through Health care Products and Hygiene Products segments. The company offers health care products, including ointments and creams, cough drops, and tablets; and hygiene products, such as feminine hygiene and other skin care hygiene products, as well as feminine care pads. It also provides baby care products comprising nappies, pants, and baby wipes; grooming products; laundry products; hair care products; home, personal and skin care, and oral products. The company sells its products under the Vicks, Whisper, Pampers, Ariel, Tide, Gillette, Head & Shoulders, Herbal Essences, Pantene, Ambi Pur, Oral-B, Olay, and Old Spice brands through mass merchandisers, as well as grocery, membership club, drug, department, and high frequency stores. The company was incorporated in 1964 and is based in Mumbai, India. Procter & Gamble Hygiene and Health Care Limited operates as a subsidiary of The Procter & Gamble Company.
READ MORE ›Market & Price
Valuation
Profitability & Returns
Balance Sheet & Liquidity
Ownership
Financial Snapshot
Growth (CAGR)
PROS
- Strong return on equity of 114.9%.
- Healthy ROCE of 135.4%.
- Profit CAGR of 14.2% over 5 years.
- Generates positive free cash flow.
CONS
- Trading 31.8% below its 52-week high.
- In a downtrend (50-DMA below 200-DMA).
* The pros and cons are auto-generated from financial metrics.
Price Chart
Technical Trend
Computed from daily close history using EMA cross, slope, and RSI signals.
Note: intraday data is not stored locally. “Hourly” uses the most recent 10 daily candles as a short-term proxy.
Fundamental Growth
No fundamental data available for this stock.
Figures from the latest reported periods. CAGR is computed across the displayed window (quarterly CAGR is annualised assuming 4 quarters per year).
Peer comparison
Peer companies in the same sector (Consumer Defensive).
| # | Name | CMP ₹ | P/E | Mkt Cap | Div Yld % | ROCE % | ROE % | Rev CAGR 5Y % | Profit CAGR 5Y % |
|---|---|---|---|---|---|---|---|---|---|
| 1 | PGHH Procter & Gamble Hygiene and Health Care Limited NSE | 9,651.00 | 36.63 | ₹31,327.86 Cr | 2.38% | 135.44% | 114.93% | 4.13% | 14.16% |
| 2 | HINDUNILVR Hindustan Unilever Limited NIFTY50NSE | 2,153.50 | 47.62 | ₹5.06 L Cr | 2.04% | 22.15% | 21.60% | 2.31% | 14.12% |
| 3 | ITC ITC Limited NIFTY50NSE | 286.90 | 17.39 | ₹3.59 L Cr | 5.58% | 36.47% | 29.34% | 3.65% | 2.54% |
| 4 | NESTLEIND Nestlé India Limited NIFTY50NSE | 1,421.50 | 78.10 | ₹2.74 L Cr | 0.84% | 59.30% | 76.34% | 17.01% | 23.05% |
| 5 | DMART Avenue Supermarts Limited NSE | 4,054.50 | 88.49 | ₹2.64 L Cr | - | 16.41% | 12.94% | 17.21% | 7.69% |
| 6 | VBL Varun Beverages Limited NSE | 528.00 | 56.17 | ₹1.79 L Cr | 0.38% | 19.44% | - | 17.26% | 26.57% |
| 7 | TATACONSUM Tata Consumer Products Limited NIFTY50NSE | 1,178.40 | 75.78 | ₹1.17 L Cr | 0.85% | 8.29% | 6.94% | 13.87% | 8.61% |
| 8 | MARICO Marico Limited NIFTY_MIDNSE | 821.70 | 60.60 | ₹1.06 L Cr | 0.49% | 39.00% | 41.39% | 12.00% | 10.61% |
| 9 | GODREJCP Godrej Consumer Products Limited NSE | 1,029.30 | 56.49 | ₹1.05 L Cr | 1.94% | 21.44% | 15.10% | 4.59% | 3.02% |
Quarterly Results
Figures in INR.
| Metric | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|
| Revenue | - | 989.13 Cr | 935.16 Cr | 1,148.85 Cr | 1,259.91 Cr | 937.67 Cr |
| Cost of Revenue | - | 394.73 Cr | 341.17 Cr | 445.20 Cr | 421.97 Cr | 356.81 Cr |
| Gross Profit | - | 594.40 Cr | 593.99 Cr | 703.65 Cr | 837.94 Cr | 580.86 Cr |
| Operating Expenses | - | 395.10 Cr | 336.91 Cr | 428.17 Cr | 445.64 Cr | 372.11 Cr |
| Operating Income | - | 199.30 Cr | 257.08 Cr | 275.48 Cr | 392.30 Cr | 208.75 Cr |
| EBITDA | - | 228.78 Cr | 273.86 Cr | 294.66 Cr | 414.21 Cr | 230.78 Cr |
| Interest Expense | - | 5.77 Cr | 7.00 L | 3.60 Cr | 2.67 Cr | 3.11 Cr |
| Pretax Income | - | 212.66 Cr | 264.70 Cr | 281.78 Cr | 402.04 Cr | 218.11 Cr |
| Tax Provision | - | 56.56 Cr | 72.64 Cr | 71.92 Cr | 100.58 Cr | 64.98 Cr |
| Net Income | - | 156.10 Cr | 192.06 Cr | 209.86 Cr | 301.46 Cr | 153.13 Cr |
| Diluted EPS | - | 48.09 | 59.17 | 64.65 | 92.87 | 47.17 |
Profit & Loss (Annual)
Figures in INR.
| Metric | Jun 2021 | Jun 2022 | Jun 2023 | Jun 2024 | Mar 2026 |
|---|---|---|---|---|---|
| Revenue | - | 3,792.45 Cr | 3,905.21 Cr | 4,191.57 Cr | 4,281.59 Cr |
| Cost of Revenue | - | 1,762.11 Cr | 1,880.82 Cr | 1,839.16 Cr | 1,565.15 Cr |
| Gross Profit | - | 2,030.34 Cr | 2,024.39 Cr | 2,352.41 Cr | 2,716.44 Cr |
| Operating Expenses | - | 1,235.90 Cr | 1,199.96 Cr | 1,403.55 Cr | 1,582.83 Cr |
| Operating Income | - | 794.44 Cr | 824.43 Cr | 948.86 Cr | 1,133.61 Cr |
| EBITDA | - | 854.21 Cr | 909.21 Cr | 1,022.70 Cr | 1,213.51 Cr |
| Interest Expense | - | 11.19 Cr | 11.38 Cr | 27.00 Cr | 9.45 Cr |
| Pretax Income | - | 790.14 Cr | 839.47 Cr | 939.20 Cr | 1,166.63 Cr |
| Tax Provision | - | 214.39 Cr | 161.33 Cr | 264.18 Cr | 310.13 Cr |
| Net Income | - | 575.75 Cr | 678.14 Cr | 675.02 Cr | 856.50 Cr |
| Diluted EPS | 200.79 | 177.37 | 208.91 | 207.95 | - |
Compounded Sales Growth
| 5 Years: | 4.13% |
| 1 Year: | -3.80% |
Compounded Profit Growth
| 5 Years: | 14.16% |
| 1 Year: | -1.90% |
Stock Price Performance
| 1 Year: | -29.55% |
| 6 Months: | -23.66% |
| 3 Months: | -16.03% |
| 1 Month: | -6.94% |
Balance Sheet (Annual)
Figures in INR.
| Metric | Jun 2021 | Jun 2022 | Jun 2023 | Jun 2024 | Mar 2026 |
|---|---|---|---|---|---|
| Total Assets | - | 1,682.57 Cr | 2,137.32 Cr | 1,858.56 Cr | 1,803.54 Cr |
| Current Assets | - | 1,135.09 Cr | 1,495.70 Cr | 1,199.68 Cr | 1,143.97 Cr |
| Cash & Equivalents | - | 624.98 Cr | 963.83 Cr | 573.67 Cr | 557.02 Cr |
| Inventory | - | 234.02 Cr | 219.80 Cr | 225.56 Cr | 217.93 Cr |
| Receivables | - | 192.08 Cr | 216.28 Cr | 240.83 Cr | 242.77 Cr |
| Total Liabilities | - | 945.00 Cr | 1,191.29 Cr | 1,083.70 Cr | 1,050.07 Cr |
| Current Liabilities | - | 859.63 Cr | 1,085.03 Cr | 980.66 Cr | 935.23 Cr |
| Long Term Debt | - | - | - | - | - |
| Total Debt | - | 5.10 Cr | 4.03 Cr | 3.08 Cr | 87.00 L |
| Total Equity | - | 737.57 Cr | 946.03 Cr | 774.86 Cr | 753.47 Cr |
| Shares Outstanding | - | 3.25 Cr | 3.25 Cr | 3.25 Cr | 3.25 Cr |
Cash Flows (Annual)
Figures in INR.
| Metric | Jun 2021 | Jun 2022 | Jun 2023 | Jun 2024 | Mar 2026 |
|---|---|---|---|---|---|
| Operating Cash Flow | - | 573.10 Cr | 825.77 Cr | 470.53 Cr | 924.08 Cr |
| Investing Cash Flow | - | -26.85 Cr | -9.91 Cr | 1.06 Cr | 11.37 Cr |
| Financing Cash Flow | - | -568.94 Cr | -477.01 Cr | -861.75 Cr | -844.80 Cr |
| Capital Expenditure | - | -49.80 Cr | -44.44 Cr | -44.68 Cr | -49.54 Cr |
| Free Cash Flow | - | 523.30 Cr | 781.33 Cr | 425.85 Cr | 874.54 Cr |
| Net Change in Cash | - | -22.69 Cr | 338.85 Cr | -390.16 Cr | 90.65 Cr |
Ratios (Annual)
Figures in %.
| Metric | Jun 2021 | Jun 2022 | Jun 2023 | Jun 2024 | Mar 2026 |
|---|---|---|---|---|---|
| Gross Margin % | - | 53.5% | 51.8% | 56.1% | 63.4% |
| Operating Margin % | - | 20.9% | 21.1% | 22.6% | 26.5% |
| Net Margin % | - | 15.2% | 17.4% | 16.1% | 20.0% |
| ROE % | - | 78.1% | 71.7% | 87.1% | 113.7% |
| ROCE % | - | 96.5% | 78.3% | 108.1% | 130.6% |
Shareholding Pattern
Analyst View
Analyst aggregate. Targets and ratings update periodically; not investment advice.
Latest News
Recent headlines for PGHH